Best Buy Gains
Mylan Labs (MYL ) sees 92 cents to $1.15 fiscal 2006 earnings per share (adjusted), and $1.20 to $1.74 fiscal 2007 earnings per share. It announces a $1.25 billion stock buyback and doubles annual dividend to 24 cents. The company plans to out-license nebivolol, its highly anticipated next-generation beta blocker.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.